Not logged in Share Save
The Incidence Of Breast Cancer In Ovarian Cancer Patients With BRCA Mutations: A Multicentre Retrospective Cohort Study. Yongue, Gabriella; Counsell, Nicholas; Morgan, Robert D.; Tookman, Laura; Devlin, Michael-John; Miller, Rowan; Modawi, Mumin; Leytes, Sophia; Hunt, Ashton; Clamp, Andrew R.; Evans, Gareth R.; Jayson, Gordon C.; Elyashiv, Osnat; Levy, Tally; Abu Remilah, Areen; Ledermann, Jonathan A.; Nicum., Shibani Share Save
Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer Morgan, Robert D.; Wang, Xin; Barnes, Bethany M.; Spurgeon, Laura; Carrot, Aurore; Netto, Daniel; Hasan, Jurjees; Mitchell, Claire; Salih, Zena; Desai, Sudha; Shaw, Joseph; Winter-Roach, Brett; Schlecht, Helene; Burghel, George J.; Clamp, Andrew R.; Edmondson, Richard J.; You, Benoit; Evans, D. Gareth R.; Jayson, Gordon C.; Taylor, Stephen S. Share Save
The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors Carucci, Margherita; Clamp, Andrew; Zhou, Cong; Hurt, Chris; Glasspool, Rosalind; Monaghan, Phillip J.; Thirkettle, Sally; Wheatley, Michael; Mahmood, Madia; Narasimham, Monica; Cox, Tracy; Morrison, Hilary; Campbell, Susan; Nelson, Annmarie; Holland-Hart, Daniella; Hopewell-Kelly, Noreen; Thomas, Abin; Porter, Catharine; Slusarczyk, Magdalena; Irving, Alys; Dive, Caroline; Adams, Richard; Jayson, Gordon C. Share Save
Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene Morgan, Robert D.; Burghel, George J.; Flaum, Nicola; Schlecht, Helene; Clamp, Andrew R.; Hasan, Jurjees; Mitchell, Claire; Salih, Zena; Moon, Sarah; Hogg, Martin; Lord, Rosemary; Forde, Claire; Lalloo, Fiona; Woodward, Emma R.; Crosbie, Emma J.; Taylor, Stephen S.; Jayson, Gordon C.; Evans, D. Gareth R. Share Save
ICON9: International phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy Nicum, S.; Ledermann, J. A.; Mileshkin, L.; Jayson, G. C.; Gourley, C.; Michael, A.; Lord, R.; Mackay, H.; Hall, M.; Tookman, L.; Banerjee, S.; Harnett, P.; Macdonald, I.; Lee, Y. C.; Elyashiv, O.; Wilkinson, K.; Farrelly, L.; Counsell, N. Share Save
Association between chemotherapy response score (CRS) and tumour homologous recombination deficiency (tHRD) in women with newly diagnosed FIGO stage IIIC/IV high-grade serous ovarian cancer (HGSOC) Britton, F.; Zhou, C.; Burghel, G. J.; Schlecht, H.; Desai, S.; Barnes, B.; Clamp, A. R.; Hasan, J.; Mitchell, C. L.; Salih, Z.; Edmondson, R.; Evans, G. D.; Jayson, G. C.; Taylor, S.; Morgan, R. D. Share Save
Testing unselected women with newly diagnosed high-grade serous ovarian cancer (HGSOC) for germline pathogenic variants (PVs) in mismatch repair (MMR) genes is unnecessary Spurgeon, L.; Burghel, G. J.; Schlecht, H.; Clamp, A. R.; Hasan, J.; Mitchell, C. L.; Salih, Z.; Woodward, E. R.; Crosbie, E.; Taylor, S.; Jayson, G. C.; Evans, G. D.; Morgan, R. D. Share Save
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer Nicum, Shibani; Mcgregor, Naomi; Austin, Rachel; Collins, Linda; Dutton, Susan; Mcneish, Iain; Glasspool, Rosalind; Hall, Marcia; Roux, Rene; Michael, Agnieszka; Clamp, Andrew; Jayson, Gordon; Kristeleit, Rebecca; Banerjee, Susana; Mansouri, Anita Share Save
Correlation between chemotherapy response score (CRS) and germline BRCA1/2 (gBRCA) status in women diagnosed with FIGO stage IIIC/IV high-grade serous ovarian cancer (HGSOC) Netto, D.; Wang, X.; Barnes, B.; Clamp, A. R.; Hasan, J.; Mitchell, C. L.; Salih, Z.; Winter-Roach, B.; Edmondson, R.; Shaw, J.; Desai, S.; Schlecht, H.; Burghel, G. J.; Taylor, S.; Evans, G.; Jayson, G. C.; Morgan, R. D. Share Save
Share Save
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade serous or endometrioid ovarian cancer: A multi-national observational study Morgan, R. D.; Clamp, A. R.; Barnes, B.; Schlecht, H.; Yarram-Smith, L.; Wallis, Y.; Morgan, S.; Valganon, M.; Hudson, E.; McKenna, S.; Sundar, S.; Nicum, S.; Brenton, J. D.; Kristeleit, R.; Banerjee, S.; McNeish, I.; Ledermann, J. A.; Taylor, S.; Evans, G.; Jayson, G. C. Share Save
Home Parenteral Nutrition in Patients with Advanced Cancer: Quality Outcomes from a Centralized Model of Care Delivery Kopczynska, Maja; Teubner, Antje; Abraham, Arun; Taylor, Michael; Bond, Ashley; Clamp, Andrew; Wight, Rebecca; Salih, Zena; Hasan, Jurjees; Mitchell, Claire; Jayson, Gordon C.; Lal, Simon Share Save
A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours El Helali, Aya; Plummer, Ruth; Jayson, Gordon C.; Coyle, Vicky M.; Drew, Yvette; Mescallado, Nerissa; Harris, Noor; Clamp, Andrew R.; McCann, Janine; Swaisland, Helen; Kennedy, Richard D.; Cranston, Aaron N.; Wilson, Richard H. Share Save
Share Save
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing? Morgan, Robert D.; Burghel, George J.; Flaum, Nicola; Bulman, Michael; Smith, Philip; Clamp, Andrew R.; Hasan, Jurjees; Mitchell, Claire L.; Salih, Zena; Woodward, Emma R.; Lalloo, Fiona; Crosbie, Emma J.; Edmondson, Richard J.; Wallace, Andrew J.; Jayson, Gordon C.; Evans, D. Gareth R. Share Save
c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial Morgan, Robert D.; Ferreras, Cristina; Peset, Isabel; Avizienyte, Egle; Renehan, Andrew G.; Edmondson, Richard J.; Murphy, Alexander D.; Nicum, Shibani; Van Brussel, Thomas; Clamp, Andrew R.; Lambrechts, Diether; Zhou, Cong; Jayson, Gordon C. Share Save
Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial Moreno, Victor; Barretina-Ginesta, Maria-Pilar; Garcia-Donas, Jesus; Jayson, Gordon C.; Roxburgh, Patricia; Vazquez, Raul Marquez; Michael, Agnieszka; Anton-Torres, Antonio; Brown, Richard; Krige, David; Champion, Brian; McNeish, Iain Share Save
Share Save
Multi-maintenance olaparib in relapsed, platinum-sensitive BRCA-mutant high-grade serous ovarian carcinoma (MOLTO): A phase II feasibility study Morgan, R. D.; Clamp, A. R.; Ryder, W. D. J.; Wheeler, C.; Buckley, E.; Truelove, J.; Murphy, A. D.; Hasan, J.; Mitchell, C. L.; Burghel, G. J.; White, D.; Price, M.; Bhaskar, S. S.; Shaw, J.; Dive, C.; Wallace, A. J.; O'Connor, J. P.; Rothwell, D.; Edmondson, R. J.; Jayson, G. C. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
